Encyclopedia of Cancer. Springer-Verlag (2015)
Chang CC, Campoli M, Ferrone S (2005) Classical and nonclassical HLA class I antigen and NK Cellactivating ligand changes in malignant cells: current challenges and future directions. Adv Cancer Res 93:189–234
Mittal D, Gubin MM, Schreiber RD, Smyth MJ (2014) New insights into cancer immunoediting and its three component phase – elimination, equilibrium and escape. Curr Opin Immunol 27:16–25
Naidoo J, Page DB, Wolchok JD (2014) Immune modulation for cancer therapy. Br J Cancer.
Neeson P, Paterson Y (2006) Effects of the tumor microenvironment on the efficacy of tumor immunotherapy. Immunol Invest 35:359–394
Singh R, Paterson Y (2007) Immunoediting sculpts tumor epitopes during immunotherapy. Cancer Res 67:1887–1892
[contact-form-7 id=»5168″ title=»Контактная форма 1″]